EnteroMedics wins European approval for Maestro RC weight loss device

March 30, 2011 by MedCity News

EnteroMedics Inc. lands CE Mark approval for its Maestro RC weight loss system and begins taking steps for approval in Australia.


EnteroMedics Inc. (NSDQ:ETRM) received CE Mark approval for the Maestro RC system.

The St. Paul, Minn.-based company previously announced its intention to target approval in other countries in its annual report, and stated that it had completed initial steps to both work toward regulatory approval and commercialize the neuroblocking product in Australia.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.